Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Gains from Investment Securities (2017 - 2026)

Evolus filings provide 9 years of Gains from Investment Securities readings, the most recent being $4000.0 for Q1 2026.

  • On a quarterly basis, Gains from Investment Securities changed N/A to $4000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$6.4 million, a 188.87% decrease, with the full-year FY2025 number at -$6.4 million, down 188.92% from a year prior.
  • Gains from Investment Securities hit $4000.0 in Q1 2026 for Evolus, up from -$4.5 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $7.2 million in Q4 2024 to a low of -$4.5 million in Q4 2025.
  • Median Gains from Investment Securities over the past 5 years was $17000.0 (2023), compared with a mean of $65428.6.
  • Biggest five-year swings in Gains from Investment Securities: soared 6016.67% in 2023 and later tumbled 1044.51% in 2025.
  • Evolus' Gains from Investment Securities stood at -$3.9 million in 2022, then dropped by 12.34% to -$4.4 million in 2023, then surged by 261.88% to $7.2 million in 2024, then tumbled by 162.86% to -$4.5 million in 2025, then soared by 100.09% to $4000.0 in 2026.
  • The last three reported values for Gains from Investment Securities were $4000.0 (Q1 2026), -$4.5 million (Q4 2025), and -$1.9 million (Q3 2025) per Business Quant data.